IN REVIEW

Genetic Counselling for Schizophrenia in the Era of Molecular Genetics

Kathleen A Hodgkinson, MSc1,2, Jillian Murphy, MSc, CCGC2, Sheri O'Neill, MSc, CCGC2, Linda Brzustowicz, MD3, Anne S Bassett, MD, FRCPC4

Objective: To review the role of genetic counselling for individuals with psychiatric illnesses.
Method: Using schizophrenia as an example and including updated information about a genetic subtype (22q deletion syndrome), we discuss the value of the genetic counselling process in psychiatry, with support from the literature and our clinical experience.
Results: Genetic counselling, the process through which knowledge about the genetics of illnesses is shared, provides information on the inheritance of illnesses and their recurrence risks; addresses the concerns of patients, their families, and their health care providers; and supports patients and their families dealing with these illnesses. For comprehensive medical management, this service should be available to all individuals with schizophrenia and their families.
Conclusions: New findings in the genetics of psychiatric illness may have important clinical implications for patients and their families.

(Can J Psychiatry 2001;46:123-130)

Key Words: genetic counselling, schizophrenia, 22q deletion syndrom, psychiatric genetics

Burgeoning interest in the genetics of schizophrenia and other major psychiatric disorders in the 1970s and 1980s led to several papers addressing the issue of genetic counselling for these conditions (1–13). Since then, we have gained appreciable knowledge, both in the field of genetic counselling and in the field of psychiatric genetics, which has helped to shape how genetic information about these psychiatric illnesses is conveyed to patients and families in the 21st century. In this paper, we review the genetic counselling process and use schizophrenia as an example to outline current knowledge about its genetics and issues arising in genetic counselling, including those pertaining to a genetic subtype of schizophrenia.


Manuscript received and accepted January 2001.
1Doctoral Candidate, Genetics Department, Memorial University of Newfoundland, St John’s, Newfoundland.
2Genetic Counsellor, Schizophrenia Research Program, Queen Street Division, Centre for Addiction and Mental Health, Toronto, Ontario.
3Associate Professor, Department of Genetics and Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Newark–Piscataway, New Jersey.
4Associate Professor, Department of Psychiatry, University of Toronto; Head, Genetics Section, Schizophrenia Research Program, Queen Street Division, Centre for Addiction and Mental Health, Toronto, Ontario.
Address for correspondence: Dr A Bassett, Schizophrenia Research Program, Queen Street Division, Centre for Addiction and Mental Health, 1001 Queen Street West, Toronto, ON  M6J 1H4
e-mail: anne.bassett@utoronto.ca

What is Genetic Counselling?

The term genetic counselling was coined by Sheldon Reed in the 1950s (14); it is a well-defined process that should ideally occur for any disorder wherein a significant risk to relatives is present (15). A formal definition of genetic counselling was established at the beginning of the 1970s by the American Society of Human Genetics (15) (Figure 1). This definition describes genetic counselling as a communication process that provides genetic information in a nondirective manner, facilitates decision making, and supports the individual seeking counselling (consultand) and the individual’s family.

Genetic counselling is traditionally provided for 1) mendelian disorders with a straightforward inheritance pattern (for example, dominant and recessive) of both pediatric and adult onset; 2) nonmendelian disorders of complex genetic etiology (for example, multifactorial) of both pediatric and adult onset; 3) genetic syndromes; 4) prenatal diagnosis of genetic conditions; and 5) teratogen assessment in pregnancy (16). Genetic counselling is provided by health-care professionals trained in genetics—primarily, by genetic counsellors (who are typically graduates from Master’s programs or equivalently trained nurses) and medical geneticists.